Skip to main content
GROW
NASDAQ Finance

U.S. Global Investors Discloses Material Weakness, Restates Q3 2026 EPS

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Asset Management Stocks · Financial
Sentiment info
Negative
Importance info
8
Price
$2.59
Mkt Cap
$26.769M
52W Low
$2.2
52W High
$3.65
52W Position info
18% above low
Off High info
29% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

GROW sits 18% above its 52-week low of $2.2 on elevated volume (2.0× avg).

Summary

U.S. Global Investors will restate its Q3 2026 EPS due to a calculation error and disclosed a material weakness in internal controls, though core financial results remain unchanged.


Key Events · Corporate Governance and Compliance · GROW

  • Non-Reliance on Financial Statements

    The Audit Committee concluded that previously issued consolidated financial statements for the three and nine months ended March 31, 2026, should no longer be relied upon.

  • EPS Restatement Due to Calculation Error

    Basic and diluted EPS for the three months ended March 31, 2026, were overstated by $0.02, and by $0.01 for the nine-month period, due to an omission in the weighted-average shares calculation.

  • Core Financials Unaffected

    The error did not impact the company's revenues, expenses, net income (loss), cash flows, or financial position.

  • Material Weakness in Internal Controls

    Management identified a material weakness in internal control over financial reporting as of March 31, 2026, related to a failure in the review control for weighted average shares outstanding.


Analysis · GROW · Finance

The company announced it can no longer rely on its Q3 2026 financial statements due to an error in EPS calculation, leading to a material weakness in internal controls. While the error did not affect core financials like revenue or net income, the disclosure of control deficiencies is a significant governance concern that can impact investor confidence in financial reporting accuracy.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GROW was trading at $2.59 on NASDAQ in the Finance sector, with a market capitalization of approximately $26.8M. The 52-week trading range was $2.20 to $3.65. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GROW - Latest Insights

GROW
Nov 12, 2026, 4:14 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.52
Real-time Price: $2.66 info
Change: +$0.1406 (+6%) info
Market Cap: $29.642M info
GROW
Sep 03, 2026, 4:21 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.27
Real-time Price: $2.66 info
Change: -$0.6094 (-19%) info
Market Cap: $29.642M info
GROW
Jun 05, 2026, 4:54 PM EDT
Filing Type: 10-Q/A
Importance Score:
8
Price at Filing: $2.67
Real-time Price: $2.66 info
Change: -$0.0094 (-0.35%) info
Market Cap: $29.642M info
GROW
Jun 05, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.67
Real-time Price: $2.66 info
Change: -$0.0094 (-0.35%) info
Market Cap: $29.642M info
GROW
Jun 04, 2026, 10:21 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $2.62
Real-time Price: $2.66 info
Change: +$0.0423 (+2%) info
Market Cap: $29.642M info